Document:

Exhibit
10.1

 

AGREEMENT
BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND HARRY LANDER

 

Agreement
made on made on January 23, 2019 by and between Harry Lander (“Consultant”), a natural person whose address is at
36 Robinson Rd, #13-0, Singapore and Zander Therapeutics, Inc. (“Company”), a Nevada corporation whose address is
4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as “Party”
and collectively as “Parties”.

 

WHEREAS
Company desires the Consultant to provide services as the Company’s Senior Scientific Consultant.

 

WHEREAS,
the Consultant desires to provide services to the Company as the Company’s Senior Scientific Consultant.

 

THEREFORE,
it is agreed as follows:

 

1.
SCOPE OF SERVICES: Consultant shall assist the Company with Its development of therapies involving checkpoint NR2F6 and commercial
anti-parasitic therapies.

 

2.
TERM: the term shall be 3 years beginning with the execution date of this agreement.

 

The
Term of this Agreement shall commence on January 25, 2019 and shall expire on January 24, 2022. The term of this Agreement may
be extended by mutual agreement.

 

3.
INDEPENDENT CONTRACTOR

 

The
Parties are independent contractors. Nothing in this Agreement shall be deemed to constitute a partnership or joint venture between
the Parties or constitute any Party to be the agent of the other Party for any purpose.

 

4.
NON DISCLOSURE

 

(a)
All information, whether in oral, written, graphic, electronic or other form, disclosed by the Company to the Consultant
shall be deemed to be “Proprietary Information.” In particular, Proprietary Information includes, without
limitation, any trade secrets, confidential information, ideas, inventions or research and development information; matters
of a technical nature, including technology; notes, products, know-how, engineering or other data (including test data and
data files); specifications, processes, techniques, formulae or work-in-process; manufacturing, planning or marketing
procedures, clinical data and regulatory strategies or information; accounting, financial or pricing procedures or
information, budgets or projections, or personnel or salary structure/compensation information; information regarding
suppliers, clients, customers, employees, contractors, investors or investigators of the Company, information which has been
designated in writing as confidential by the Company; programs, procedures (including operating procedures), processes,
methods, guidelines, policies, proposals or contracts; computer software, data bases or programming; and any other
information which, if divulged to a third party, could have an adverse impact on the Company, or on any third party to which
it owes a confidentiality obligation. In addition, “Proprietary Information” includes any of the foregoing
relating to the past, present or future operations, organization, projects, finances, business interests, methodology or
affairs of any third party to which the Company owes a duty of confidentiality including, without limitation, the mere fact
that the Company is or may be working with or for any client.

 

    	 	1	 

     

    

 

(b)
The obligations of confidentiality shall not apply to any Proprietary Information that was known by the Consultant at the time
of disclosure to it by such Company, or that is independently developed or discovered by the Consultant after disclosure by such
Company, without the aid, application or use of any item of such Company’s Proprietary Information, as evidenced by written
records; now, or subsequently becomes, through no act or failure to act on the part of the Consultant, generally known or available;
is disclosed to the Consultant by a third party authorized to disclose it; or is required by law or by court or administrative
order to be disclosed; provided, that the Consultant shall have first given prompt notice to such Company of such required disclosure.

 

(c)
Consultant shall exercise due care to prevent the unauthorized use or disclosure of the Company’s Proprietary Information,
and shall not, without the Company’s prior written consent, disclose or otherwise make available, directly or indirectly,
any item of the Company’s Proprietary Information to any person or entity other than those employees, independent contractors
or agents of the Consultant (collectively, “Representatives”), to the extent such Representatives reasonably need
to know the same in order to evaluate such Proprietary Information, to participate in the business relationship between the parties,
or to make decisions or render advice in connection therewith. Consultant shall advise its Representatives who have access to
the Company’s Proprietary Information of the confidential and proprietary nature thereof, and agrees that such Representatives
shall be bound by terms of confidentiality and restrictions on use with respect thereto that are at least as restrictive as the
terms of this Agreement.

 

(d)
Consultant shall exercise due care to prevent the unauthorized use or disclosure of the Company’s Proprietary Information,
and shall not, without the Company’s prior written consent, disclose or otherwise make available, directly or indirectly,
any item of the Company’s Proprietary Information to any person or entity other than those employees, independent contractors
or agents of the Consultant (collectively, “Representatives”), to the extent such Representatives reasonably need
to know the same in order to participate in any business relationship between the parties, or to make decisions or render advice
in connection therewith. Consultant shall advise its Representatives who have access to the Company’s Proprietary Information
of the confidential and proprietary nature thereof, and agrees that such Representatives shall be bound by terms of confidentiality
and restrictions on use with respect thereto that are at least as restrictive as the terms of this Agreement.

 

(e)
Consultant shall use the Company’s Proprietary Information solely for the purposes of performing his duties pursuant to
this Agreement and shall not make any other use of the Company’s Proprietary Information without the Company’s specific
written authorization.

 

(f)
All Proprietary Information of the Company (including all copies thereof) shall be and at all times remain the property of such
Company, and all non-oral Proprietary Information of the Company which is then in the Consultant’s possession or control
shall be destroyed or returned to the Company promptly upon its request at any time, and in any event, no later than 60 days following
any expiration or termination of this Agreement.

 

    	 	2	 

     

    

 

(g)
Nothing in this Agreement shall be construed, by implication or otherwise, as a grant of any right or license to trademarks, inventions,
copyrights or patents, as a grant of a license to either Consultant to use any of the Company’s Proprietary Information
except as expressly set forth herein.

 

(h)
The provisions of Section 4 of this Agreement shall survive until such time as all Confidential Information disclosed hereafter
becomes publically known and made generally available through no action or inaction of Consultant.

 

5.
REPRESENTATIONS AND WARRANTIES

 

(a)
Company is a corporation duly organized, validly existing and in good standing under the laws of the state its incorporation and
has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

 

(b)
The execution, delivery and performance of this Agreement by Company does not and shall not constitute Company’s breach
of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of
or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument
to which the Company is a party, or by which Company is or may be bound.

(c)
Consultant has the requisite power and authority to enter into and perform his obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

 

(d)
The execution, delivery and performance of this Agreement by Consultant does not and shall not constitute Consultant’s breach
of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of
or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument
to which the Consultant is a party, or by which Consultant is or may be bound.

 

6.
CONSIDERATION

 

Consultant
shall receive 10,000,000 shares of the Company’s Series M preferred stock (“Consideration Stock”) as full, sole
and complete consideration for providing services pursuant to this Agreement, such Consideration Stock to be issued as follows:

 

7.
RESTRICTED SECURITIES ACKNOWLEDGEMENT

 

Consultant
acknowledges that any securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act
of 1933 shall constitute “restricted securities” as that term is defined in Rule 144 promulgated under the Securities
Act of 1933, and shall contain the following restrictive legend:

 

“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS
OF ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM REGISTRATION UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.”

 

    	 	3	 

     

    

 

8.
NON DISPARAGEMENT

 

During
the term of this Agreement and for a period of twelve months thereafter, Consultant and the Company mutually agree to forbear
from making, causing to be made, publishing, ratifying or endorsing any and all disparaging remarks, derogatory statements or
comments made to any party with respect to either of them or their respective officers, directors, and employees. The parties
agree and acknowledge that this Section 8 is a material term of this Agreement.

 

9.
WORK PRODUCT

 

Consultant
agrees that the Company is the sole and exclusive owner of all intellectual property, including copyrights, trademarks, patents,
inventions, work product and know-how, which may result from any work performed by the Consultant pursuant to this Agreement.
Consultant agrees that Consultant shall, upon request of the Company, execute, acknowledge, deliver and file any and all documents
necessary or useful to vest in the Company all of Consultant’s right, title and interest in and to all intellectual property,
including copyrights, trademarks, patents, inventions, work product and know-how, which may result from any work performed by
the Consultant pursuant to this Agreement. The term "Inventions" means all original works of authorship, developments,
concepts, improvements or trade secrets, whether or not patentable under law, that Consultant may individually or jointly conceive
or develop or reduce to practice, or cause to be conceived or developed or reduced to practice.

 

10.
EXECUTION

 

This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same Agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood
that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile signature page were an original thereof.

 

11.
ENTIRE AGREEMENT

 

This
Agreement constitutes a final written expression of all the terms of the Agreement between the parties regarding the subject matter
hereof, are a complete and exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings,
and representations between the parties.

 

12.
SEVERABILITY

 

If
any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of
the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties
will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefore, and upon so agreeing,
shall incorporate such substitute provision in this Agreement

 

    	 	4	 

     

    

 

14.
GOVERNING LAW, VENUE, WAIVER OF JURY TRIAL

 

All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	COMPANY	 	CONSULTANT
	By:
                                                          David                                          R. Koos

        
	 	By:
    Harry Lander
	/s/David
                                         Koos
	 	/s/Harry
                                         Lander

	Its:
    CEO	 	 
	Date:	 	Date:
	 	 	 

    	 	5Exhibit 4.1

 

	            NUMBER	 	SHARES                    

            C    

 

AKERNA
CORP.

INCORPORATED UNDER THE LAWS OF THE STATE
OF DELAWARE

CLASS A COMMON STOCK

 

SEE REVERSE FOR

CERTAIN DEFINITIONS

 

	This Certifies that	 	CUSIP 00973W 102
	is the owner of	 	 

 

FULLY PAID AND NON-ASSESSABLE SHARES
OF THE PAR VALUE OF $0.0001 EACH

OF THE CLASS ACOMMON STOCK OF

 

AKERNA CORP.

 

transferable on the books of the Corporation
in person or by duly authorized attorney upon surrender of this certificate properly endorsed. This certificate and the shares
represented hereby are subject to the laws of the State of Delaware, and to the Amended and Restated Certificate of Incorporation
and Bylaws of the Corporation, as now or hereafter amended. 

 

This certificate is not valid unless
countersigned by the Transfer Agent and registered by the Registrar.

 

Witness the facsimile seal of the Corporation
and the facsimile signatures of its duly authorized officers.

 

	Dated:	 	 	 	 
	 	 	 	 	 
	CHAIRMAN	 	[INSERT SEAL HERE]	 	CHIEF EXECUTIVE OFFICER

 

The following abbreviations, when used
in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable
laws or regulations:

 

	TEN COM	-	as tenants in common	UNIF GIFT MIN ACT-	 	 Custodian 	 	 
	TEN ENT	-	as tenants by the entireties  	 	 	(Cust)	 	(Minor)	 
	JT TEN	-	as joint tenants with right of survivorship	under Uniform Gifts to Minors	 	 
	 	 	and not as tenants in common	Act	 	 	 	 	 
	 	 	 	 	               (State)	 	 	 	 

 

Additional abbreviations may also be used
though not in the above list.

  

Akerna Corp.

 

The Corporation will furnish without charge
to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or other special
rights of each class of stock or series thereof of the Corporation and the qualifications, limitations, or restrictions of such
preferences and/or rights. This certificate and the shares represented thereby are issued and shall be held subject to all
the provisions of the Certificate of Incorporation and all amendments thereto and resolutions of the Board of Directors providing
for the issue of shares of Preferred Stock (copies of which may be obtained from the secretary of the Corporation), to all of which
the holder of this certificate by acceptance hereof assents.

 

    	 

     

    

 

For value received,                      hereby
sell, assign and transfer unto

 

PLEASE INSERT SOCIAL SECURITY OR OTHER

IDENTIFYING NUMBER OF ASSIGNEE

 

	 	 

 

	(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)
	 
	 

 

	 	 	 shares

of the capital stock represented by the within Certificate,
and do hereby irrevocably constitute and appoint

 

	 	 	 Attorney

to transfer the said stock on the books of the within named
Corporation will full power of substitution in the premises.

 

Dated_____________

	 	 
	 	Notice:	 	The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular, without alteration or enlargement or any change whatever.

Signature(s) Guaranteed:

 

	 	 
	THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]